Regio- and stereospecific synthesis of novel 3-enynyl-substituted thioflavones/flavones using a copper-free palladium-catalyzed reaction

Journal of Organic Chemistry

Volumn 70, Issue 18, 2005, Pages 7179-7187

  Pal, Manojit ^a   Dakarapu, Rambabu ^a   Parasuraman, Karuppasamy ^a   Subramanian, Venkataraman ^a   Yeleswarapu, Koteswar Rao ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; CHEMICAL ACTIVATION; CHEMICAL REACTIONS; PALLADIUM; SYNTHESIS (CHEMICAL);

ACETYLENIC MOIETIES; ARYLALKYNES; C-C BOND-FORMING REACTION; PALLADIUM-CATALYZED CROSS COUPLING;

ORGANIC COMPOUNDS;

ALKYNE; COPPER; COPPER IODIDE; FLAVONE DERIVATIVE; IODIDE; PALLADIUM; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; THIOFLAVONE DERIVATIVE; THIOL DERIVATIVE; TRIETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CATALYST; CHEMICAL BOND; CHEMICAL PARAMETERS; CHEMICAL REACTION; CROSS COUPLING REACTION; METHODOLOGY; REGIOSELECTIVITY; REGIOSPECIFICITY; STEREOSPECIFICITY; SYNTHESIS;

CATALYSIS; FLAVONES; MOLECULAR CONFORMATION; PALLADIUM;

EID: 24144439075     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo050828+     Document Type: Article

References (77)

1. Khattab, A. M.; Grace, M. H.; El-Khrisy, E. A. Pharmazie 2001, 56, 661.
2. (a) Nohara, A.; Umetani, T.; Sanno, Y. Tetrahedron 1974, 30, 3553 and references therein.
3. (b) Horie, T.; Tominaga, H.; Kawamura, Y.; Hada, T.; Ueda, N.; Amano, Y.; Yamamoto, S. J. Med. Chem. 1991, 34, 2169.
4. (c) For 2,3-diarylflavone as a COX-2 inhibitor, see: Joo, Y. H.; Kim, J. K.; Kang, S.-H.; Noh, M.-S.; Ha, J.-Y.; Choi, J. K.; Lim, K. M.; Lee, C. H.; Chung, S. Bioorg. Med. Chem. Lett. 2003, 13, 413.
5. (a) van Acker, F. A. A.; Hageman, J. A.; Haenen, G. R. M. M.; van der Vijgh, W. J. F.; Bast, A.; Menge, W. M. P. B. J. Med. Chem. 2000, 43, 3752.
6. (b) Nohara, A.; Kuriki, H.; Saijo, T.; Ukawa, K.; Murata, T.; Kanno, M.; Sanno, Y. J. Med. Chem. 1975,18, 34.
7. (c) van Acker, F. A. A.; Hageman, J. A.; Haenen, G. R. M. M.; van der Vijgh, W. J. F.; Bast, A.; Menge, W. M. P. B. J. Med. Chem. 2000, 43, 3752.
8. (d) Nussbaumer, P.; Lehr, P.; Billich, A. J. Med. Chem. 2002, 45, 4310.
9. For the 5-lipoxygenase inhibiting property of 3-alkylflavones, see: (e) Horie, T.; Tominaga, H.; Kawamura, Y.; Hada, T.; Ueda, N.; Amano, Y.; Yamamoto, S. J. Med. Chem. 1991, 34, 2169.
10. (a) Konishi, M.; Ohkuma, H.; Matsumoto, K.; Tsuno, T.; Kamei, H.; Miyake, T.; Oki, T.; Kawaguchi, H.; Van Duyne, G. D.; Clardy, J. J. Antibiot. 1989, 42, 1449.
11. (b) Nussbaumer, P.; Leitner, I.; Mraz, K.; Stutz, A. J. Med. Chem. 1995, 38, 1831.
12. (a) Spector, T.; Porter, D. J. T.; Nelson, D. J.; Baccanari, D. P.; Davis, S. T.; Almond, M. R.; Khor, S. P.; Amyx, H.; Cao, S.; Rustum, Y. M. Drugs Future 1994, 19, 565.
13. (b) Kundu, N. G.; Das, B.; Spears, C. P.; Majumdar, A.; Kang, S. I. J. Med. Chem., 1990, 33, 1975.
14. (c) Kundu, N. G.; Dasgupta, S. K.; Chaudhuri, L. N.; Mahanty, J. S.; Spears, C. P.; Shahinian, A. H. Eur. J. Med. Chem. 1993, 28, 473.
15. (d) Pronounced cytotoxicity and significant antiviral activity have been reported for several potent inhibitors of TS, see for example: De Clercq, E.; Balzarini, J.; Torrence, P. F.; Mertes, M. P.; Schmidt, C. L.; Shugar, D.; Barr, P. J.; Jones, A. S.; Verhelst, G.; Walker, R. T. Mol. Pharmacol. 1981, 19, 321.
16. For 3,4-disubstituted furanones, see: (a) Padakanti, S.; Veeramaneni, V. R.; Pattabiraman, V. R.; Pal, M.; Yeleswarapu, K. R. Tetrahedron Lett. 2002, 43, 8715.
17. (b) Pal, M.; Rao, V. V.; Srinivas, P.; Murali, N.; Akhila, V.; Premkumar, M.; Rao, C. S.; Misra, P.; Ramesh, M.; Rao, Y. K. Indian J. Chem. 2003, 42B, 593.
18. (c) Pal, M.; Veeramaneni, V. R.; Nagabelli, M.; Kalleda, S. R.; Misra, P.; Casturi, S. R.; Yeleswarapu, K. R. Bioorg. Med. Chem. Lett. 2003, 13, 1639.
19. (d) Padakanti, S.; Pal, M.; Yeleswarapu, K. R. Tetrahedron 2003, 59, 7915.
20. (a) For 3,4-diaryl maleic anhydride, see: Pattabiraman, V. R.; Padakanti, P. S.; Veeramaneni, V. R.; Pal, M.; Yeleswarapu, K. R. Synlett 2002, 947.
21. (b) For 2-substituted benzo[6]furans, see: Pal, M.; Subramanian, V.; Yeleswarapu, K. R. Tetrahedron Lett. 2003, 44, 8221.
22. (c) For isocoumarins, see: Subramanian, V.; Batchu, V. R.; Barange, D.; Pal, M. J. Org. Chem. 2005, 70, 4778-4783.
23. (d) For phthalides, see: Kundu, N. G.; Pal, M.; Nandi, B. J. Chem. Soc., Perkin Trans. 1 1998, 561.
24. (a) A preliminary report on part of this work has appeared; see: Pal, M.; Parasuraman, K.; Subramanian, V.; Dakarapu, R.; Yeleswarapu, K. R. Tetrahedron. Lett. 2004, 45, 2305.
25. (b) For the synthesis of 3-alkynyl-substituted flavones, see: Pal, M.; Subramanian, V.; Parasuraman, K.; Yeleswarapu, K. R. Tetrahedron 2003, 59, 9563.
26. For studies on biological properties of 6-enynyl-substituted flavones, see: Artali, R.; Barili, P. L.; Bombieri, G.; Re, P. D.; Marchini, N.; Meneghetti, F.; Valenti, P. Farmaco 2003, 58, 875.
27. For the synthesis of 3-alkyl/alkenyl flavones, see: (a) Lokshin, V.; Heynderickx, A.; Samat, A.; Pepe, G.; Guglielmetti, R. Tetrahedron Lett. 1999, 40, 6761.
28. (b) Goyal, S.; Parthasarathy, M. R. Indian J. Chem. 1992, 31B, 391.
29. (c) For a review, see; Ghosh, C. K.; Ghosh, C. Indian J. Chem. 1997, 36B, 968.
30. (d) Nakazumi, H.; Endo, T.; Sonoda, H.; Kitao, T. J. Heterocycl. Chem. 1985, 22, 821.
31. (e) Dhara, M. G.; De, S. K.; Mallik, A. K. Tetrahedron Lett. 1996, 37, 8001.
32. For synthesis via a Ru-catalyzed reaction, see: (a) Melis, K.; Samulkiewicz, P.; Rynkowski, J.; Verpoort, F. Tetrahedron Lett. 2002, 43, 2713 and references therein.
33. For synthesis via a Pd-catalyzed reaction, see: (b) Trost, B. M.; Chan, C.; Ruhter, G. J. Am. Chem. Soc. 1987, 109, 3486.
34. (c) Beard, R. L.; Klein, E. S.; Standeven, A. M.; Escobar, M.; Chandraratna, R. A. S. Bioorg. Med. Chem. Lett. 2001, 11, 765.
35. (d) Thadani, A. N.; Rawal, V. H. Org. Lett. 2002, 4, 4321.
36. (e) Nuss, J. M.; Levine, B. H.; Rennels, R. A.; Heravi, M. M. Tetrahedron Lett. 1991, 32, 5243.
37. (f) Negishi, E.; Noda, Y.; Lamaty, F.; Vawter, E. J. Tetrahedron Lett. 1990, 31, 4393.
38. (g) Torii, S.; Okumoto, H.; Tadokoro, T.; Nishimura, A.; Rashid, A. Tetrahedron Lett. 1993, 34, 2139.
39. (h) Chen, L.; Li, C.-J. Tetrahedron Lett. 2004, 45, 2771.
40. For synthesis via a Lewis acid-catalyzed reaction, see: (i) Ishikawa, T.; Aikawa, T.; Mori, Y.; Saito, S. Org. Lett. 2003, 5, 51.
41. For a Cu-catalyzed procedure, see: Bates, C. G.; Saejueng, P.; Venkataraman, D. Org. Lett. 2004, 6, 1441.
42. (a) Heck, R. F. J. Am. Chem. Soc. 1968, 90, 5518.
43. (b) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 16, 4467.
44. (c) de Meijere, A.; Meyer, F. E. Angew. Chem., Int. Ed. Engl. 1994, 33, 2379.
45. (d) Sonogashira, K. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I., Eds.; Pergamon: Oxford, UK, 1991; Vol. 3, Chapter 2.4.
46. (a) Gonzalez, J. J.; Francesch, A.; Cardenas, D. J.; Echavarren, A. M. J. Org. Chem. 1998, 63, 2854.
47. (b) Stara, I. G.; Stary, I.; Kollarovic, A.; Teply, F.; Saman, D.; Fiedler, P. Tetrahedron 1998, 54, 11209.
48. (c) Very recently, when this work was in progress, an example on the unexpected formation of porphyrinic enyne was reported, see: Chen, Y.-J.; Lee, G.-H.; Peng, S.-M.; Yeh, C.-Y. Tetrahedron Lett. 2005, 46, 1541;
49. corrigendum: Tetrahedron Lett. 2005, 46, 3265.
50. (a) Dimerization of terminal alkynes to the corresponding diyne is often a side reaction under the Sonogashira coupling conditions and this oxidative homocoupling (Glaser coupling) predominates in the presence of oxygen or other reagents, see for example: Kundu, N. G.; Pal, M.; Chowdhury, C. J. Chem. Res., Synop. 1993, 432.
51. See also: Lei, A.; Srivastava, M.; Zhang, X. J. Org. Chem. 2002, 67, 1969.
52. Batsanov, A. S.; Collings, J. C.; Fairlamb, I. J. S.; Holland, J. P.; Howard, J. A. K.; Lin, Z.; Marder, T. B.; Parsons, A. C.; Ward, R. M.; Zhu, J. J. Org. Chem. 2005, 70, 703 and references therein. CuI in the presence of amine base seemed to have a significant role in such oxidative homocoupling of terminal acetylenes.
53. (b) For a discussion, see: Pal, M.; Parasuraman, K.; Gupta, S.; Yeleswarapu, K. R. Synlett 2002, 1976.
54. See also: (c) Urgaonkar, S.; Verkade, J. G. J. Org. Chem. 2004, 69, 5752.
55. (d) Park, S. B.; Alper, H. Chem. Commun. 2004, 1306.
56. 6) δ 179.1, 149.6, 136.9 (2C), 135.3, 132.0, 131.8, 130.2, 129.4 (2C), 128.3 (2C), 128.1 (2C), 128.0, 126.8, 126.6, 101.7, 78.7, 71.9, 63.6, 31.5 (2C), 29.1 (2C).
57. (f) This product was detected while monitoring the reaction using TLC where it appeared below the desired product IIIa when visualized under UV light.
58. (a) 3-Iodothioflavone and 3-iodoflavone were prepared according to a known procedure, see: Zhang, F. J.; Li, Y. L. Synthesis 1993, 565.
59. (b) All the terminal alkynes used are commercially available.
60. (c) For the synthesis of simple 3-alkynyl flavones from 3-iodoflavone having no substituent at the 2-position under Sonogashira condition, see: Yao, T.; Zhang, X.; Larock, R. C. J. Am. Chem. Soc. 2004, 126, 11164.
61. (d) Kálai, T.; Kulcsár, G.; Ösz, E.; Jekö, J.; Sümegi, B.; Hideg, K. ARKIVOC 2004, Part vii, 266.
62. (a) Larock, R. C.; Tian, Q J. Org. Chem. 1998, 63, 2002.
63. 4, see: Dang, H.; Garcia-Garibay, M. A. J. Am. Chem. Soc. 2001, 123, 355.
64. 3) δ 178.8, 162.9, 162.0, 151.9, 141.7, 141.6, 136.9, 136.3, 134.7, 131.7 (2C), 130.1 (2C), 129.8, 129.4, 128.9, 128.7, 128.3 (2C), 127.8, 125.7, 125.6 (2C), 125.3, 121.5, 114.8 (2C), 114.5 (2C), 89.0, 84.7, 69.9, 56.7.
65. -.
66. For a review see: Amatore, C.; Jutand, A. Acc. Chem. Res. 2000, 33, 314.
67. (b) Wu, M.-J.; Wei, L.-M.; Lin, C.-F.; Leou, S.-P.; Wei, L.-L.; Tetrahedron 2001, 57, 7839. See also ref 8b.
68. (c) The stability of A may be accounted for by the contribution from the following resonating structures. Diagram presented.
69. (d) Nuss, J. M.; Rennels, R. A.; Levine, B. H. J. Am. Chem. Soc. 1993, 115, 6991.
70. (a) Pfeffer, M. Red. Trav. Chim. Pays-Bas 1990, 109, 567.
71. (b) Larock, R. C.; Yum, E. K.; Refvik, M. D. J. Org. Chem. 1998, 63, 7652.
72. (c) Cacchi, S. Pure Appl. Chem. 1990, 62, 713.
73. (d) A similar effect imparted by hydroxyl groups of acetylenic alcohols was observed during palladium-catalyzed hydroarylation of propargylic alcohols, see: Arcadi, A.; Bernocchi, E.; Burini, A.; Cacchi, S.; Marinelli, F.; Pietroni, B. Tetrahedron 1988, 44, 481 and references therein.
74. 16a in their study.
75. See for example: (a) Ghosh, C. K.; Bandyopadhyay, C.; Biswas, S.; Chakravarty, A. K. Indian J. Chem. Sect. B 1990, 29, 814.
76. (b) Yao, T.; Zhang, X.; Larock, R. C. J. Am. Chem. Soc. 2004, 126, 11164.
77. 50 of 32 and 33 μM respectively on a tested panel of cancer cell lines [e.g. HT29 (colon), H460 (lung), LoVo (colon), etc.].